URGN · UroGen Pharma Ltd.

$42.84 -0.25 (-0.58%)

Market Cap

$2.13B

48.88M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-20	2026-08-18
10-Q	2026-08-05	2026-06-30
8-K	2026-08-05	—
8-K	2026-06-23	2026-06-22
8-K	2026-06-02	—
Investor Event Transcript	2026-05-19	2026-06-30
10-Q	2026-05-06	2026-03-31
8-K	2026-05-06	—
DEF 14A	2026-04-30	2025-12-31
8-K	2026-03-02	2026-02-26
8-K	2026-03-02	—
10-K	2026-03-02	2025-12-31
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
8-K	2025-08-27	2025-08-26
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
DEF 14A	2025-07-15	2025-08-11
8-K	2025-07-03	2025-06-30
8-K	2025-06-13	2025-06-12
10-Q	2025-05-12	2025-03-31
8-K	2025-05-12	—
10-K/A	2025-04-30	2024-12-31
10-K	2025-03-10	2024-12-31
8-K	2025-03-10	—
8-K	2025-02-20	2025-02-14
8-K	2025-01-14	—
8-K	2024-11-06	—
10-Q	2024-11-06	2024-09-30
8-K	2024-10-09	2024-10-07
8-K	2024-09-24	2024-09-23
8-K	2024-09-13	2024-09-12
8-K	2024-08-15	2024-08-14
10-Q	2024-08-13	2024-06-30
8-K	2024-08-13	—
8-K	2024-08-08	2024-08-06
DEF 14A	2024-07-01	2024-08-07
8-K	2024-06-18	2024-06-17
8-K	2024-06-13	—
10-Q	2024-05-13	2024-03-31
8-K	2024-05-13	—
10-K/A	2024-04-29	2023-12-31
8-K	2024-03-14	—
10-K	2024-03-14	2023-12-31
8-K	2024-03-04	—
8-K	2024-03-01	—
8-K	2024-02-07	—
8-K	2024-01-17	2024-01-16
8-K	2024-01-02	2023-12-28
8-K	2023-11-14	—

Showing 1–50 of 107 filings

Key facts CIK 1668243 CUSIP M96088105 13F (30d) 166 filings 166 filers Visit website Investor relations